Phosphorylation is the most studied protein post-translational modification (PTM) in biological systems, since it controls cell growth, proliferation, survival, and other processes. High-resolution/high mass accuracy mass spectrometers are used to identify protein phosphorylation sites due to their speed, sensitivity, selectivity, and throughput. The protocols described here focus on two common strategies: (1) identifying phosphorylation sites from individual proteins and small protein complexes, and (2) identifying global phosphorylation sites from whole-cell and tissue extracts. For the first, endogenous or epitope-tagged proteins are typically immunopurified from cell lysates, purified via gel electrophoresis or precipitation, and enzymatically digested into peptides. Samples can be optionally enriched for phosphopeptides using immobilized metal affinity chromatography (IMAC) or titanium dioxide (TiO 2 ) and then analyzed by microcapillary liquid chromatography/tandem mass spectrometry (LC-MS/MS). Global phosphorylation site analyses that capture pSer/pThr/pTyr sites from biological sources sites are more resource and time consuming and involve digesting the whole-cell lysate, followed by peptide fractionation by strong cation-exchange chromatography, phosphopeptide enrichment by IMAC or TiO 2 , and LC-MS/MS. Alternatively, the protein lysate can be fractionated by SDS-PAGE, followed by digestion, phosphopeptide enrichment, and LC-MS/MS. One can also immunoprecipitate only phosphotyrosine peptides using a pTyr antibody followed by LC-MS/MS. Curr. .27. C 2012 by John Wiley & Sons, Inc.
INTRODUCTION
Phosphorylation of proteins plays an important role in cellular signaling events and metabolic processes, and is therefore the most studied post-translational modification (White, 2008; Choudhary and Mann, 2010; Zarei et al., 2011) . The determination of phosphorylated peptides in a biological sample is most easily achieved using mass spectrometry, due to sensitivity, selectivity, and throughput (Yates et al., 2009 ). The phosphoproteome of mammalian cells and tissues is complex and displays a wide dynamic range of varying concentration. To reduce the complexity of the human proteome and determine the phospho-proteome content, it is necessary to use either enrichment, purification, or sample fractionation at the protein or peptide level (Eyrich et al., 2011) . These methods utilize gel electrophoresis, ion-exchange chromatography, and microcapillary HPLC.
Proteomic approaches to analyzing phosphorylation usually involve selective isolation of phosphopeptides and subsequent fragmentation in a mass spectrometer to identify both the peptide sequence and phosphorylation site. Suitable mass spectrometers are capable of high resolution and high mass accuracy and include hybrid instruments containing
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Orbitrap analyzers and time-of-flight (TOF) mass analyzers (Ahmed, 2008) . In hybrid linear ion trap-Orbitrap-style mass spectrometers (LTQ-Orbitrap XL, Velos Pro Orbitrap, or Velos Elite Orbitrap series; ThermoFisherScientific; Makarov and Scigelova, 2010) , peptide precursor ions are analyzed in the Orbitrap at high resolution/high mass accuracy at ≤1 to 2 ppm mass accuracy and up to 100,000 resolution, and can then either be fragmented in the ion trap or in a collision cell for sequence/phosphorylation analysis. Alternatively, a hybrid quadrupole-TOF instrument (QqTOF) can be used (such as Xevo from Waters; 5600 from AB/SCIEX; 6500 series from Agilent; or microTOF from Bruker). The QqTOF is made up of two quadrupole mass spectrometers followed by a high-resolution TOF; peptide precursors are analyzed in the TOF, fragmented in the collision cell, and analyzed in the TOF analyzer for both sequence and modification determination. The mass accuracy is similar to Orbitrap instruments at sub 2 ppm; however, resolution is lower, on the order of ∼25K, though sufficient for most phosphopeptide applications.
It is also important to use an online HPLC instrument capable of nanoliter flow rates coupled directly to the mass spectrometer to achieve optimal sensitivity in the low femtomole to high attomole range, since many phosphorylation events are present in very low abundance (Washburn, 2008) . One can use either splitless or manual-split HPLC systems with microcapillary columns that are capable of flow rates as low as ∼200 nl/min (e.g., EASY-nLC from ThermoFisherScientific; NanoAcquity from Waters; NanoLC Ultra from Eksigent; etc.). Tandem mass spectrometry (capable of fragmentation) used in combination with nano-HPLC is referred to as microcapillary liquid chromatography/tandem mass spectrometry (LC-MS/MS).
In addition to the equipment required, informatics software is necessary to identify peptide sequences and their phosphorylated counterparts. For this purpose, database search engines such as commercially available Mascot (Perkins et al., 1999) and Sequest (Yates et al., 1995) , as well as freely available MaxQuant (Andromeda; Cox et al., 2011) and XTandem! (Falkner and Andrews, 2005) , are commonly used to interrogate protein databases for peptide/protein/PTM identifications.
The protocols in this unit focus on determining phosphorylation sites using LC-MS/MS. It is important to note that matrix-assisted laser desorption/ionization (MALDI)-based systems are also capable of identifying phosphorylation sites (Asara and Allison, 1999; Bennett et al., 2002) ; however, far more work has been performed using LC-MS-based systems.
In order to comprehensively study the functional role of phosphorylation of a specific protein of interest from a cell or tissue source, it is important to identify all phosphorylation sites of the protein from one or more biological conditions. The first step is purifying the protein in sufficient amounts (micrograms) for successful LC-MS/MS analysis (Basic Protocol 1). Since the stoichiometric level of phosphorylated peptides can be extremely low compared to the unmodified peptides, the goal is to purify as much protein as possible for optimal success. This is typically done using an epitope tag such as FLAG, HA, or Myc, or through immunoprecipitation (IP; Bonifacino et al., 1999) with a suitable antibody. The next step involves protein purification using one of two methods. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) is recommended for the case of antibody IP, followed by gel band excision and proteolytic digestion, followed by tandem mass spectrometry (LC-MS/MS). For epitope-tagged proteins, solution-based digestions are possible if detergent-free and low salt-containing buffers are used for protein elution (Alternate Protocol 1). In addition, one can choose additional steps prior to LC-MS/MS to enrich phosphorylated peptides using either metal ion affinity chromatography (IMAC; Basic Protocol 2) or titanium dioxide beads (TiO 2 ; Support Protocols 1 and 2). 
SINGLE-PROTEIN (PROTEIN COMPLEX) PHOSPHORYLATION SITE MAPPING
The following protocol focuses on identifying and mapping phosphorylation sites from a single immunopurified protein or a protein complex. This is typically used when a researcher has a targeted question and is interested in mapping phosphorylation from a single protein of interest or its strongly bound interaction partners. Proteins are generally immunopurified, separated by SDS-PAGE, excised, digested with an enzyme such as trypsin, and analyzed by LC/MS/MS (Dibble et al., 2009; Soltoff et al, 2010; TignoAranjuez et al., 2010; Egan et al., 2011; Lee et al., 2011) directly or with phosphopeptide enrichment (Soltoff et al., 2010) . Results can then be compared across different biological conditions such drug treatments and/or stimuli to find differentially regulated phosphorylation sites on a protein of interest. This in contrast to global phosphorylation site analysis, where a researcher aims to identify all phosphorylation sites from a biological sample (Basic Protocol 2). 8. Add 80 μl of the bead slurry (40 μl pure beads) to the lysate-antibody solution and incubate for 2 hr on an end-over-end rotator at 4 • C 9. Centrifuge 2 min at 2500 × g, 4 • C, then remove supernatant completely.
Materials
10. Wash the protein-antibody beads complex with 1 ml of lysis/IP buffer by rocking for 3 min at 4 • C.
11. Centrifuge 2 min at 2500 × g, 4 • C, remove supernatant, then repeat the wash described in steps 10 to 11 three times.
12. Elute the proteins from beads by adding ∼80 μl of 1× SDS sample buffer (twice the volume of pure beads) and incubating for 5 min at 95 • C. 14. Run mini SDS-PAGE at ∼120 V for ∼1 hr or until the solvent dye front reaches the bottom of the gel for optimal resolution.
15. Stain the gel with Coomassie blue stain for 1 hr at room temperature and destain the gel overnight at 4 • C with at least five solvent changes in the first 2 hr.
Staining and destaining of gels is described in UNIT 10.6. Figure 18.19 
In-gel digestion
Carrying out in-gel enzymatic digestion (Li et al., 1997) from SDS-PAGE is a low-cost and efficient method for processing samples that removes salts and/or detergents that are part of the lysis buffer and interfere with mass spectrometry analyses. It allows for both sample fractionation and separation and provides protein molecular weight information. The disadvantages are the potential loss of material incurred by the additional sample manipulation steps introduced by loading samples onto gels and potential losses during peptide extraction from gels after tryptic digestion; however, these drawbacks are relatively minor.
17. Dry the gel bands in a SpeedVac concentrator for ∼15 min with no heat.
18. Add a volume of 10 mM DTT in 100 mM NH 4 HCO 3 sufficient to cover the gel pieces, and incubate at 56 • C for 30 min, to reduce the gel.
19. Add 100% acetonitrile to shrink the gel pieces (same volume used in step 18) for ∼5 min, room temperature.
20. Remove liquid, add 55 mM IAA in 100 mM NH 4 HCO 3 to the gel at the same volume that was used for reduction (step 18), and keep in the dark (closed drawer) for 30 min at room temperature. 26. Incubate 15 min on ice, then add an additional volume of 50 mM NH 4 HCO 3 (enough to completely cover gel slice).
27. Digest overnight (>12 hr) at 37 • C in a shaking thermal incubator.
28. Add 30 to 45 μl (or as needed) of 20 mM NH 4 HCO 3 (depending on the gel size, gel must be covered) and incubate for 10 min at 37 • C with shaking. Microcentrifuge 30 sec at maximum speed, then transfer supernatant to a plain 1.5-ml microcentrifuge tube.
29. Add ∼50 to 75 μl (or as needed) of 2% formic acid/40% acetonitrile and incubate for 15 min at 37 • C with shaking. Microcentrifuge 30 sec and add supernatant to first extraction.
30. Partially dry down in SpeedVac with no heat to a final volume of 10 μl.
Tandem mass spectrometry (LC-MS/MS)
An HPLC system capable of nanoliter flow rates is needed for microcapillary reversedphase liquid chromatography tandem mass spectrometry (LC-MS/MS). This can be a split or splitless system. 31. Equip the system with a C 18 packed analytical column with typical dimensions of 75 μm i.d. × 15 cm length at a flow rate of ∼250 nl/min for optimal sensitivity.
Packed analytical columns can be purchased commerciall,y or empty columns can be purchased and self-packed with C 18 material (Lee, 2001) .
32. Set up a method for data-dependent acquisition (DDA) or "shotgun" mode over a 90-min LC-MS/MS acquisition using an appropriate high-resolution/high mass accuracy tandem mass spectrometer. (Dibble et al., 2009; Egan et al., 2011; Yang et al., 2011). 33. Inject a 3-to 5-μl aliquot (depending upon amount of starting material) of the sample onto the equilibrated column using the following conditions: initial conditions 2% HPLC buffer B; 2% B to 38% B over 90 min; 38% B to 95% B over 2 min; hold at 95% B for 4 min; 95% B to 2% B over 1 min; hold at 2% B for 12 min to re-equilibrate column. 
It is typical to collect a single MS spectrum followed by 5 to 10 MS/MS spectra per DDA cycle with a 120-sec exclusion window and a 2.5 m/z MS/MS isolation window. The mass spectrometer can be configured to include specific m/z values representing phosphopeptides of interest to increase the sensitivity of detection through "inclusion lists" or fixed targeted scan events
Interpret phosphorylation sites
Phosphorylation results in a peptide ion with a +80 Da mass increase compared to the unmodified peptide for each phosphorylated Ser, Thr, or Tyr residue. In addition, site localization can be achieved on a peptide through the fragmentation pattern, whereby fragment ions starting at the modification site will reflect the +80 Da shift. Increased confidence in phosphopeptide assignments can be gained by considering specific spectral features, for example, the facile neutral loss of phosphoric acid (-98 Da) from Ser-and Thr-phosphorylated peptides upon fragmentation (Hunter and Games, 1994; Asara and Allison, 1999) . Tyr phosphorylation tends to show a prominent loss of metaphosphoric acid . While this can help indicate the presence of a phosphate group, it can occasionally adversely affect the ability of search engines to identify phosphopeptides with sufficient scores, due to the reduction in sequence-specific fragment ions as they are transferred to the neutral loss (Boersema et al., 2009 ). This loss is more prominent during fragmentation with ion traps than with collision-cell mass analyzers.
37. Set threshold search engine scores so that the FDR is ≤1.0%.
This assures that quality spectra and true phosphopeptide matches are accepted in the analysis.
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38. For critically important phosphorylation sites, view the MS/MS spectrum to verify that the b-ions (fragment ions from the N-terminus of the peptide) and y-ions (fragment ions from C-terminus) are consistent with the predicted sequence and modification site from the search engine. (Gwinn et al., 2008) . Software is also available to perform site localization of phosphorylation using probabilistic algorithms such as ASCORE (Beausoleil et al., 2006) within ScaffoldPTM software (Proteome Software, Inc., or http://ascore.med.harvard.edu/) and MaxQuant (Cox and Mann, 2008; Cox et al., 2009) 
ACETONE PRECIPITATION OF PROTEIN SAMPLES (FOR IP ELUTION WITH PEPTIDE OR SMALL MOLECULE)
Acetone precipitation cleans protein samples of both salts and detergents (ThermoScientific, 2009 6. Decant and properly dispose of the supernatant, being careful to not dislodge the protein pellet.
7. Repeat steps 3 to 6 one more time.
8. Allow the acetone to evaporate from the uncapped tube at room temperature for
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In-solution digestion (precipitated protein) 9. Add 20 μl of 10 mM DTT in 100 mM NH 4 HCO 3 to the sample pellet from step 8 and incubate for 30 min at 56 • C.
10. Add 20 μl of 55 mM IAA in 100 mM NH 4 HCO 3 and incubate for 30 min at room temperature in the dark.
11. Dilute sample to 200 μl with 50 mM NH 4 HCO 3 , pH 8.3 (same for gel digests).
12. Add 2.0 μg of trypsin (i.e., 2 μl of 1 μg/μl TPCK modified trypsin prepared in 50 mM acetic acid).
13. Incubate overnight at 37 • C with shaking.
14. The next day, add 20 μl of 5% TFA to stop digestion. Use 1 to 2 μl to check that the pH is ∼3.5 (pH paper is sufficient).
15. Concentrate sample in a SpeedVac concentrator to a final volume of 10 μl.
Purify and concentrate solution digest
16. Prepare C 18 ZipTip by aspirating/expelling 20 μl of 100% acetonitrile. Discard washes and repeat one time.
17. Aspirate/expel 20 μl of ZipTip elution buffer (0.1% TFA/40% acetonitrile), discard washes, and repeat two times. 
PHOSPHOPEPTIDE ENRICHMENT USING PROTEA BIOSCIENCES TiO 2 SPIN TIPS
Affinity-based enrichment of phosphopeptides using immobilized metal affinity chromatography (IMAC) can enhance the number of identified phosphopeptides in an analysis. Typically, one can use commercially available reagents that include Fe 3+ , Ga 3+ , or titanium dioxide (TiO 2 ) (Larsen et al., 2005) . TiO 2 has lower affinity for multiphosphopeptides and works better for enrichment of monophosphorylated peptides, while IMAC has a higher efficiency for the recovery of multi-phosphorylated peptides (Thingholm et al., 2006) . Sometimes, TiO 2 can also nonspecifically bind acidic nonphosphorylated peptides (contain D and E residues). This can be significantly reduced by including 2,5-dihydroxybenzoic acid (DHB), phthalic acid, or glycolic acid, and high concentrations of TFA in the loading buffer (Thingholm et al., 2008; Villen and Gygi, 2008) .
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For enrichment of phosphopeptides, several commercial kits are available including IMAC (PHOS-Select Iron affinity gel, SIGMA) and TiO 2 (TiO 2 SpinTips, Protea Biosciences, described in this protocol; and Phos-Trap kit, Perkin-Elmer described in Support Protocol 2). It is recommended that half of the simple peptide mixture be analyzed directly by LC-MS/MS and the second half of the sample be used for phosphopeptide enrichment using Support Protocol 1 or 2.
Additional Materials (also see Basic Protocol 1)
Peptide sample Protea TiO 2 SpinTips Sample Prep Kit (Protea Biosciences) including: SpinTip adapers TiO 2 Reconstitution and Wash Solution 1 TiO 2 Elution Solution 2-ml microcentrifuge tubes
Prepare SpinTips
1. Ensure that the packing material is at the bottom of the tip by gently tapping the tip to displace any packing material sticking to the top of the red cap.
2. Place SpinTip adapter onto a 2-ml microcentrifuge tube.
3. Wash the SpinTip to wet the packing material by adding 100 μl TiO 2 Reconstitution and Wash Solution 1 to the top of the SpinTip using a repeating pipettor.
4. Centrifuge the system 3 to 5 min at 4000 × g, room temperature. Discard eluate and repeat steps 3 to 4.
Binding 5. Reconstitute ∼5 to 20 μl of the peptide sample in ∼200 μl TiO 2 Reconstitution and Wash Solution 1 and vortex until the sample is completely dissolved.
6. Load 200 μl of the sample solution by adding it to the top of the SpinTip, and centrifuge 3 to 5 min at 4000 × g, room temperature.
7. Wash the sample to elute salts and other loosely bound components by adding 100 μl TiO 2 Reconstitution and Wash Solution 1 to the top of the SpinTip.
8. Centrifuge 3 to 5 min at 4000 × g, room temperature. Discard eluate and repeat steps 7 to 8.
Elution
9.
Transfer the SpinTip to a new, clean 2-ml centrifuge tube to collect the sample during elution.
10. Elute the sample by adding 100 μl TiO 2 Elution Solution to the top of the SpinTip. Centrifuge 3 to 5 min at 4000 × g, room temperature. Repeat the SpinTip sample elution two times using the same elution solution. 2. Dispense 200 μl of bead suspension per 1.5-ml microcentrifuge tube.
3. Place on a magnet to catch the beads and remove the liquid without removing any beads.
4. Wash beads with 200 μl of binding buffer (from kit). Add buffer "off" the magnet and lightly shake to suspend the beads evenly in solution for 1 min.
Put tray (tube) on magnet to remove liquid without removing beads; repeat two times.
Binding and washing 6. Dilute purified peptide sample 1:10 in binding buffer, but do not exceed 150 μl in total volume. Use a SpeedVac concentrator to partially evaporate the sample prior to dilution, if necessary.
7. Add the sample solution to the beads and incubate for 60 min while shaking continuously to keep the beads suspended in the solution.
8. Put tube on magnet, remove liquid (not beads) from the tubes, and transfer to a tube labeled "TiO 2 flowthrough."
These peptide mixtures can be analyzed in the mass spectrometer if one is interested in non-phosphorylated peptides.
9. Wash the beads with 200 μl of binding buffer for 1 min, then put tube on magnet and remove liquid; repeat three times.
10. Wash the beads with 200 μl of wash buffer (from kit) for 1 min, then put tube on magnet and remove liquid.
Elution 11. Elute the phosphopeptides by adding 35 μl of elution buffer (from kit) to beads and incubate for 15 min with continuous shaking.
12. Place tube on a magnet to catch the beads; aspirate solution, but DO NOT draw up any beads, and add the elution containing the sample to a 12 × 32-mm autosampler vial.
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13. Add 50 μl of HPLC buffer A and concentrate using SpeedVac concentrator to 5 μl.
14. Inject entire 5-μl volume onto LC-MS/MS system.
BASIC PROTOCOL 2
GLOBAL PHOSPHORYLATION ANALYSIS (Ser/Thr/Tyr)
In addition to determining the phosphorylation sites from purified proteins or protein complexes, it is possible to perform global phosphorylation site profiling directly from whole-cell extracts and tissue sources (Kirkpatrick et al., 2005; Olsen et al., 2010) . Using the procedures below, researchers have discovered up to 36,000 in vivo phosphorylation sites from various mouse organ tissues, although most global phosphorylation studies result in several thousand phosphorylation sites detected (Beausoleil et al., 2004; Oppermann et al., 2009; Pan et al., 2009; Olsen et al., 2010) . While these analyses are very time-consuming and require milligrams of material, offline strong cation exchange (SCX) peptide fractionation, and a dozen 2-hr LC-MS/MS runs, one can achieve hundreds to thousands of phosphopeptide identifications from a biological sample. In general, the ratio of threonine, serine, and tyrosine protein phosphorylation is approximately 90%, 10%, and 0.05%, respectively (Hunter and Sefton, 1980) .
Below is a protocol for determining Ser/Thr/Tyr phosphopeptide identifications on a global scale, as well as a protocol for isolating just the Tyr phosphopeptides from cell and tissue extracts. Figure 18 .19.3 shows a flowchart outlining the sequential steps used in the following protocol for identifying potentially thousands of phosphorylation sites.
Materials
Cells of interest, in log phase Urea lysis buffer (see recipe) Liquid nitrogen (−196
• C) Bradford protein assay kit (BioRad; also see UNIT 10.1A) 45 mM DTT: mix 180 μl of 1.25 M DTT (19.25 g/100 ml) with 5 ml HPLC-grade water; add to sample at ∼1/10 dilution (e.g., 0.5 ml DTT per 5-ml sample) 110 mM IAA: Dissolve 209 mg iodoacetamide (IAA) in 10 ml HPLC-grade water;
add to sample at ∼1/10 dilution Sequencing grade modified trypsin (100 μg/vial; Worthington, cat. no. LS02122) 50 mM ammonium bicarbonate (NH 4 HCO 3 ) 20%, 10%, 1%, 0.1% (v/v) 2. Lyse sufficient cells (∼10 7 to 10 8 ) or tissue (∼150 to 200 mg) to produce ∼15 to 20 mg of protein in ∼5 to 10 ml of urea lysis buffer with protease/phosphatase inhibitors.
For lysis of frozen tissue, grind it using a liquid nitrogen stainless steel mortar with ceramic pestle until it is a powder, let liquify at 4 • C, and then immediately add urea lysis buffer containing protease/phosphatase inhibitors.
3. Aspirate/expel the lysate several times with a 1 ml (P-1000) pipet tip.
4. Sonicate for 1 min at 4 • C using a bath sonicator on medium setting, repeat two times.
5. Centrifuge lysate in a 15-ml tube 5 min at 14,000 × g, 15 • C to remove cell debris.
Retain supernatant.
6. Determine the protein concentration in a small aliquot of the supernatant using the Bradford assay. 11. Add 150 to 200 μl trypsin solution to the lysate (∼100:1 substrate/protease ratio).
12. Incubate the solution overnight at 37 • C in a shaking incubator (∼450 rpm).
13. The next day, stop the protease reaction by adding 1/40 the solution volume of 20% TFA, for a final concentration of 0.5% TFA.
14. Let mixture stand for 10 min at room temperature.
15. Clear the sample of debris by centrifuging 10 min at 14,000 × g, 15 • C. Retain the supernatant containing digested peptides.
Purification
Samples first need to be purified prior to subsequent pTyr IP (Basic Protocol 3) or SCX fractionation to optimize antibody binding and charge separation.
16. Check pH of cleared sample to be sure it is between 2.0 and 3.0.
17. Prewet 6-cc/500 mg C 18 Sep-Pak with 3 ml of acetonitrile.
18. Wash with 3 ml of 0.1% TFA/40% acetonitrile.
19. Wash with 3 ml of 0.1% TFA, then discard wash; repeat two times.
20. Load peptide digestion sample (from step 15) onto Sep-Pak.
21. Wash column with 3 ml of 0.1% TFA, then discard wash; repeat two times.
22. Elute peptides with 1 ml of 0.1% TFA/40% acetonitrile, repeat two times, and combine eluates for 3 ml total volume.
23. Divide sample into two microcentrifuge tubes. Dry down partially in SpeedVac with no heat to ∼200 to 400 μl, then combine both samples into one 1.5-ml microcentrifuge tube.
24. Dry down completely to a pellet in a SpeedVac with no heat.
At this point it is possible to proceed to Basic Protocol 3 for pTyr site identification. For SCX peptide fractionation, continue with steps 25 to 55, below.
Strong cation exchange (SCX) (peptide fractionation)
This approach fractionates the digested peptides according to their solution charge using strong cation exchange (SCX) chromatography. Phosphopeptide enrichment with IMAC is then used after peptide separation prior to LC-MS/MS. In SCX chromatography, trypsinized peptides are eluted from the column according to their solution charge state.
Most phosphorylated peptides at pH 3 carry 1 + or 2 + charges, since the peptide charge is reduced by 1 for each negatively charged phosphate group (Olsen and Mann, 2004; Villen and Gygi, 2008) . Most nonphosphorylated tryptic peptides carry 2 + and 3 + charges in solution. However, other factors including hydrophobicity also play a role in SCX separation. In addition, attention should be paid to multi-phosphorylated peptides containing a low or neutral net charge, because these peptides are unable to bind to
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the stationary phase and elute in the flow-through fraction. SCX separation should take place using an HPLC system capable of 3 ml/min flow rates offline from the LC-MS/MS system. This procedure is frequently referred to as multidimensional protein identification technology (MUDPIT) Wolters et al., 2001 ).
HPLC
25.
Degas SCX buffers A and B, purge SCX HPLC pumps, clean 1 ml sample loop and equilibrate column with 1% SCX buffer B for 14 min at 1 ml/min.
26. Load a blank sample containing only SCX buffer A onto sample loop (system in load position) to prepare the HPLC system for subsequent runs.
27. Inject the blank sample (system in inject position) and run HPLC method at a flow rate of 3 ml/min over a PolySULFOETHYL A SCX column using the following gradient conditions:
1%-35% B: 40 min 35%-50% B over 1 min 50%-100% B over 5 min 100% B for 5 min 100%-1% B over 1 min 1% B for 14 min to re-equilibrate column.
28. Dilute dried, desalted pellet from step 24 in 950 μl of SCX buffer A. Vortex to completely dissolve.
29. Inject 950 μl of sample onto a 1-ml sample loop and run SCX method as in steps 26 to 27.
Fraction collection
30. Collect 3 min (9 ml) fractions from the elution starting at time 0 min for a total of ∼15 fractions in separate 15-ml conical tubes.
31. Concentrate fractions to dryness in SpeedVac concentrator with no heat.
Purification of salts 32. Dissolve dried peptide pellet in 500 μl of 0.1% TFA.
33. Check pH of cleared sample with pH paper to be sure it is between 2.0 and 3.0, using 5 μl from each of the 12 fractions.
34. Pre-wet 3-cc/50 mg capacity C 18 Sep-Pak with 1 ml of acetonitrile (prepare one Sep-Pak per fraction).
35. Wash Sep-Pak with 1 ml of 0.1% TFA/40% acetonitrile.
36. Wash Sep-Pak with 1 ml of 0.1% TFA; repeat two times.
37. Load peptide digestion sample from step 32 onto prepared Sep-Pak 38. Wash sample on Sep-Pak with 1 ml of 0.1% TFA; repeat two times.
39. Elute peptides with 333 μl of Sep-Pak Elution Buffer in 1.5-ml microcentrifuge tube; repeat two times with fresh elution buffer and combine for 1-ml total volume.
40. Dry peptide sample completely to a pellet in a SpeedVac concentrator using no heat.
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Phosphopeptide enrichment
Since there are currently no good-quality antibodies available for the enrichment of general phosphoserine (pSer) and/or phosphothreonine (pThr) residues, there are two possible strategies for enriching all phosphorylation sites from a complex cell and/or tissue lysate: immobilized metal affinity chromatography (IMAC) using iron (step 41), or TiO 2 enrichment (see Support Protocol 1).
PHOS-Select IMAC (Sigma)
Preparation 41. Prepare 100 μl of IMAC beads by washing them with 1 ml of IMAC binding buffer, inverting the vial five times to resuspend all beads, and centrifuging 3 min at 2500 × g, room temperature, to remove the liquid. Repeat three times and prepare 50% slurry in the same buffer.
42. Prepare twelve 0.5-ml microcentrifuge tubes and place 10 μl of IMAC beads slurry into each.
Cutting the end of the pipet tip to a wider opening facilitates pipetting of beads.
Binding 43. Dissolve each dried peptide fraction obtained from step 40 in 120 μl of IMAC binding buffer, and transfer to the IMAC beads for a total volume of 130 μl.
44. Incubate peptides on beads for 60 min at room temperature with vigorous shaking.
45. During this time, prepare twelve StageTips by cutting two disks of Empore 3 M C 18 material with a cutter device from Hamilton and packing into 250-μl pipet tips (Rappsilber et al., 2007) .
46. Wash and equilibrate packed StageTips by passing 20 μl of methanol through each of the tips, followed by 20 μl of 40% acetonitrile/0.5% acetic acid, and then two 20-μl aliquots of 1% formic acid. 
SDS-PAGE PROTEIN FRACTIONATION OF WHOLE-CELL EXTRACTS
This protocol involves fractionating proteins from a whole-cell extract according to their molecular weight using SDS-PAGE followed by in-gel digestion and subsequent IMAC or TiO 2 phosphopeptide enrichment and LC-MS/MS analysis. This is sometimes called GeLC-MS (Chang et al., 2007) . Several steps have been abbreviated since SDS-PAGE is described In Basic Protocol 1.
For materials, see Basic Protocol 1.
1. Lyse the material in lysis/IP buffer containing protease/phosphatase inhibitors for 45 min with rocking at 4 • C. Centrifuge for 20 min at full speed at 4 • C. Retain supernatant.
2. Load samples onto denaturing polyacrylamide gels according to the capacity of the minigel (fixed or gradient) and electrophorese until the dye front runs completely to the bottom of the gel.
Stain with Coomassie and destain overnight.
The stain is mostly used here as a lane and protein amount indicator and is not intended to resolve bands.
4. Cut gel into ∼10 to 12 equal sections and place each gel piece in a 1.5-ml centrifuge tube.
5. Follow Basic Protocol 1, steps 17 to 30, for in-gel digestion, and dry to a final volume of ∼10 μl.
6. For phosphopeptide enrichment of gel-digested fractions, follow either Support Protocol 1 (TiO 2 ) or Basic Protocol 2 (IMAC) to prepare sample for LC-MS/MS.
7. Run the mass spectrometer according to Basic Protocol 1, steps 31 to 33, with the following change: the LC-MS/MS gradient and acquisition time should be increased from 90 min to ∼120 min per sample to increase peptide/protein coverage.
BASIC PROTOCOL 3
PHOSPHOTYROSINE (pTyr) SITE IDENTIFICATION
Although phosphotyrosine appears in only 0.05% of cellular protein phosphorylation, it is the critical key player in many signaling events starting from receptor tyrosine kinases. In addition, 20% of the kinome represents protein tyrosine kinases, revealing the importance of tyrosine phosphorylation events (Manning et al., 2002) . Due to the larger size of the modified tyrosine residue, it is more qualified for developing antibodies for purification of proteins or peptides from complex cellular extracts containing pTyr residues (Rush et al., 2005) . 
Preparation
Before the pTyr immunoprecipitation can be performed, the solution must be desalted and the pH must be adjusted to neutral.
1. Add 1.4 ml lysis/IP buffer to digested and purified sample pellet from step 24 of Basic Protocol 2, then sonicate in 4 • C water bath at medium setting, three times for 1 min each time.
2. Check pH. If less than pH 5, add 1 M Tris base dropwise until the solution is pH 6.0 to 7.5.
3. Centrifuge 5 min at 1,800 × g, 4 • C. Keep supernatant, and place on ice.
Bind to pTyr Ab 4. Using 15 to 20 mg of total protein prior to digestion, add ∼80 μg of P-Tyr-100 mAb beads in suspension.
5. Incubate for 2 hr on an end-over-end rotator at 4 • C.
6. Centrifuge 1 min at 2500 × g, 4 • C.
7. Remove supernatant completely with gel-loading tips to avoid removal of beads.
8. Wash beads with 1 ml lysis/IP buffer, agitate by inverting five times, and centrifuge 1 min at 2,500 × g, 4 • C. Discard supernatant. Repeat one more time.
9. Wash beads with 1 ml HPLC-grade water (4 • C) to remove the detergents, agitate by inverting five times, then centrifuge 1 min at 2,500 × g, 4 • C. Discard supernatant. Repeat four times.
Elution 10. Elute with 55 μl of P-Tyr-100 elution buffer (0.15% TFA), tap bottom of tube several times to disrupt bead packing, and incubate 10 min at room temperature.
11. Tap again and centrifuge for a few seconds at 2500 × g. Keep supernatant.
12. Add 45 μl of 0.15% TFA, tap bottom of tube several times, and centrifuge for a few seconds at 2,500 × g. Keep supernatant (with gel loading tip) and combine with previous elution (step 11) for a total of 100 μl.
Analysis of Protein Phosphorylation
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Purification and concentration 13. Centrifuge 1 min at 2,500 × g, room temperature, to remove potential remaining agarose beads in tube.
14. Divide sample in two equal parts. 
REAGENTS AND SOLUTIONS
COMMENTARY
Background Information
Currently, apart from the very low throughput of site-specific antibodies, mass spectrometry is the only known and validated technology for identifying, and in some cases quantifying, individual sites of phosphorylation on proteins. Mass spectrometry is routinely used by researchers in the fields of molecular and cellular biology. While mass spectrometers are expensive and sophisticated pieces of equipment, often the work is performed either within a core facility or in collaboration with an analytical laboratory specializing in mass spectrometry. While high-resolution mass spectrometers are being acquired in some biology laboratories, they are not yet widespread, due to the cost of the equipment and maintenance required for optimal performance. The protocols described in this unit are designed to aid the biologist getting into the mass spectrometry field or already possessing a state-of-the art mass spectrometer, and to be a reference for collaborators of biologists already in the mass spectrometry field to optimize strategies for identifying sites of phosphorylation in biological samples. Much of the work involved in this protocol is benchlevel work with cells and proteins, and that is generally handled very well by the biologist. Mass spectrometry-level expertise comes into play for acquisition of phosphopeptide data and subsequent processing and interpretation of the acquired data. However, software has improved to the point where trained technicians can interpret the data using statistics. Additional bioinformatics analyses of the data are not described in this unit, and require expertise in those fields. 
Critical Parameters and Troubleshooting
In Vivo Phosphorylation
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